Healthcare Realty Trust Inc (HR) Q4 2025 Earnings Call Highlights: Strong Leasing Activity and …

GuruFocus News

Sat, February 14, 2026 at 6:00 AM GMT+9 4 min read

In this article:

HR

+2.72%

This article first appeared on GuruFocus.

**Normalized FFO per Share:** $1.61 for the full year 2025, exceeding the midpoint of original guidance by $0.03.

**Same-Store NOI Growth:** 4.8% for 2025, surpassing the midpoint of original guidance by 140 basis points.

**Leasing Activity:** 5.8 million square feet executed in 2025, including 1.6 million square feet of new leases.

**Tenant Retention:** Improved by 220 basis points, with an annual retention rate of 82%.

**Cash Leasing Spreads:** Improved by 60 basis points.

**G&A Expense:** Achieved $10 million run rate savings, with total G&A expense at $45 million.

**Asset Dispositions:** $1.2 billion sold at a blended 6.7% cap rate, exiting 14 noncore markets.

**Net Debt to EBITDA:** Reduced to 5.4 times from nearly a full turn higher.

**Dividend Yield:** Nearly 6% current yield to shareholders.

**Q4 2025 Normalized FFO per Share:** $0.40.

**Q4 2025 Same-Store Cash NOI Growth:** 5.5%.

**Q4 2025 FAD per Share:** $0.32, with a quarterly dividend payout ratio of 75%.

**2026 Guidance for Normalized FFO per Share:** $1.58 to $1.64, with a midpoint of $1.61.

**2026 Same-Store Cash NOI Growth Guidance:** 3.5% to 4.5%.

**2026 G&A Expense Guidance:** $43 million to $47 million.

Warning! GuruFocus has detected 10 Warning Signs with HR.

Is HR fairly valued? Test your thesis with our free DCF calculator.

Release Date: February 13, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Healthcare Realty Trust Inc (NYSE:HR) completed a revamp of its asset management platform, leading to improved cash leasing spreads and tenant retention.

The company achieved its target of $10 million in run rate G&A savings, reducing total G&A expenses to $45 million.

Healthcare Realty Trust Inc (NYSE:HR) successfully executed an asset disposition plan, selling $1.2 billion of assets at a favorable cap rate.

The company improved its balance sheet by reducing net debt to EBITDA to 5.4 times and extending debt maturities.

Healthcare Realty Trust Inc (NYSE:HR) reported strong leasing activity, executing 5.8 million square feet of leases in 2025, with tenant retention at 82%.

Negative Points

The company's 2026 FFO guidance implies flat year-over-year growth, which may be perceived as underwhelming.

Healthcare Realty Trust Inc (NYSE:HR) faces limitations on external growth due to current cost of capital and discount to intrinsic asset value.

The company anticipates refinancing a $600 million bond at a higher interest rate, which could increase interest expenses.

Healthcare Realty Trust Inc (NYSE:HR) has a finite amount of capital for acquisitions, limiting its ability to pursue external growth opportunities.

The company acknowledges challenges in executing its strategic plan, including the difficulty of making necessary personnel changes.

 






Story Continues  

Q & A Highlights

Q: Can you explain the same-store NOI guidance for 2026 and the assumptions behind it? A: Peter Scott, President and CEO, explained that the 2025 same-store NOI growth of 4.8% was strong, aided by over 100 basis points of absorption. For 2026, they expect 3.5% to 4.5% growth, driven by escalators, retention, absorption, and cash leasing spreads. They are averaging over 3% on lease deals, with retention trending towards the mid-80s, and expect positive absorption, although not as high as 2025.

Q: What are the capital expenditure expectations relative to the $1.61 normalized FFO for 2026? A: Peter Scott noted that with flat FFO expectations, they anticipate flat FAD as well, ending last year at $1.26. The maintenance capital number is included in their guidance, suggesting similar expectations for FAD as for FFO.

Q: How do you view acquisition potential given current stock prices and cap rates? A: Peter Scott stated that without acquisitions or stock buybacks, they would likely end up below their target net debt-to-EBITDA ratio. They have modest balance sheet capacity of $200 million to $300 million. They will only pursue acquisitions if the yield is greater than their implied cap rate, emphasizing disciplined capital allocation.

Q: What is the plan for dispositions going forward? A: Peter Scott mentioned $175 million in sales is embedded in their guidance, with $70 million from deals closing early in 2026. They also have a $45 million loan expected to be repaid in March. Beyond that, $60 million of dispositions are planned, potentially including noncore, non-income producing assets.

Q: How are you approaching joint ventures and potential asset acquisitions? A: Peter Scott explained that they are considering growth with existing joint venture partners who want to increase investments in outpatient medical. They are not planning new joint ventures currently but are open to it. They aim to ensure any acquisitions provide yields greater than their implied cap rate.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Terms and Privacy Policy

Privacy Dashboard

More Info